World Research and Development: Clinova – Product Pipeline Review – H2 2011

• Publication date: December 2011

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct’s proprietary databases, Clinova’s corporate website, SEC filings, investor presentations and featured press releases, both from Clinova and market -specific third party sources, put together by Global In...

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industries Direct’s proprietary databases, Clinova’s corporate website, SEC filings, investor presentations and featured press releases, both from Clinova and market -specific third party sources, put together by Global Industries Direct’s team.

Scope of the Research

- Clinova - Brief Clinova overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Clinova human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Clinova with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Clinova’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Clinova’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Clinova in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Clinova’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Clinova.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Clinova and identify potential opportunities in those areas.

Global Therapy Industry

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Clinova Snapshot 4
Clinova Overview 4
Key Information 4
Key Facts 4
Clinova – Research and Development Overview 5
Key Therapeutic Areas 5
Clinova – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
Clinova – Pipeline Products Glance 9
Clinova – Late Stage Pipeline 9
Phase III Products/Combination Treatment Modalities 9
Clinova – Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Clinova – Drug Profiles 11
CLIN 3004 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
CLIN 3007 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
CLIN 3010 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
CLIN 3011 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Clinova – Pipeline Analysis 15
Clinova – Pipeline Products by Therapeutic Class 15
Clinova – Pipeline Products by Molecule Type 16
Clinova – Firms Statement 17
Clinova – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 20
Expert Panel Validation 20
Contact Us 20
Disclaimer 20

List of Tables

Clinova, Facts and Figures 4
Clinova, Key Facts 4
Clinova – Pipeline by Therapy Area and Indication, H2 2011 6
Clinova – Pipeline by Stage of Development, H2 2011 7
Clinova – Monotherapy Products in Pipeline, H2 2011 8
Clinova – Phase III, H2 2011 9
Clinova – Pre-Clinical, H2 2011 10
Clinova - Pipeline By Therapeutic Class, H2 2011 15
Clinova – Pipeline By Molecule Type, H2 2011 16
Clinova, Other Locations 18

List of Figures

Clinova – Pipeline by Therapy Area and Indication, H2 2011 6
Clinova – Pipeline by Stage of Development, H2 2011 7
Clinova – Monotherapy Products in Pipeline, H2 2011 8
Clinova – Pipeline By Therapeutic Class, H2 2011 15